RIBOMUNIL TREATMENT OF CHRONIC-BRONCHITIS - CLINICOIMMUNOLOGICAL ASSESSMENT

Authors
BORISOVA AM KHOROSHILOVA NV PINEGIN BV EREMINA OF SIMONOVA AV KULAKOV AV DYKHANOV II GOLUBEVA NM
Citation
Am. Borisova et al., RIBOMUNIL TREATMENT OF CHRONIC-BRONCHITIS - CLINICOIMMUNOLOGICAL ASSESSMENT, Terapevticeskij arhiv, 66(3), 1994, pp. 46-49
Citations number
6
Categorie Soggetti
Medicine, General & Internal
Journal title
Terapevticeskij arhiv → ACNP
ISSN journal
00403660
Volume
66
Issue
3
Year of publication
1994
Pages
46 - 49
Database
ISI
SICI code
0040-3660(1994)66:3<46:RTOC-C>2.0.ZU;2-H
Abstract
The paper reports the results of ribomunil trial in chronic bronchitis (CB) patients who suffered from frequent exacerbations. The drug was found to act primarily on a phagocytic component of the immunity and l ocal immunity of the respiratory micosa. Because of its vaccine-like e ffect, ribomunil administration is most beneficial in CB remission. Ri bomunil treatment results in reduction of the number and duration of C B exacerbations, of the scope of antibacterial therapy.